Cardiovascular Disease is Associated with COPD Severity and Reduced Functional Status and Quality of Life

References

• Sahyoun NR, Lentzner H, Hoyert D, Trends in causes of death among the elderly. Aging Trends 2001; 1–10.
   Google Scholar
• Mannino DM, Homa DM, Akinbami LJ, Chronic obstructive pulmonary disease surveillance—United States, 1971–2000. MMWR Surveill Summ 2002; 51:1–16.
   PubMed Web of Science ®Google Scholar
• American Heart Association. Heart disease and stroke statistics—2011 update. Dallas, TX: American Heart Association, 2011.
   Google Scholar
• Regan EA, Hokanson JE, Murphy JR, Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7:32–43.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:179–187.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R, Anzueto A, Bourbeau J, Calverley P, DeGuia T, Fukuchi Y, Hui D, Jenkins C, Kocabas A, Martinez F, DeOca M, VanWeel C, Vestbo J, Woodhead M, Agusti A, Barnes P, Decramer M, Fabbri L, Jones P, Sin D, Wedzicha J. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2009. http://www.goldcopd.org/Guidelines/guidelines-resources.html.
   Google Scholar
• Ferris BG. Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 1978; 118:1–120.
   PubMed Web of Science ®Google Scholar
• ATS statement. guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005–1012.
   PubMed Web of Science ®Google Scholar
• Jones PW. Quality of life measurement for patients with diseases of the airways. Thorax 1991; 46:676–682.
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321–1327.
   PubMed Web of Science ®Google Scholar
• Mapel DW, Robinson SB, Dastani HB, The direct medical costs of undiagnosed chronic obstructive pulmonary disease. Value Health 2008; 11:628–636.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107:1514–1519.
   PubMed Web of Science ®Google Scholar
• Danesh J, Wheeler JG, Hirschfield GM, C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387–1397.
   PubMed Web of Science ®Google Scholar
• Kosmala W, Derzhko R, Przewlocka-Kosmala M, Plasma levels of TNF-alpha, IL-6, and IL-10 and their relationship with left ventricular diastolic function in patients with stable angina pectoris and preserved left ventricular systolic performance. Coron Artery Dis 2008; 19:375–382.
   PubMed Web of Science ®Google Scholar
• Sakkinen P, Abbott RD, Curb JD, C-reactive protein and myocardial infarction. J Clin Epidemiol 2002; 55:445–451.
   PubMed Web of Science ®Google Scholar
• Bittner V, Weiner DH, Yusuf S, Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. SOLVD Investigators. JAMA 1993; 270:1702–1707.
   PubMed Web of Science ®Google Scholar
• Curtis JP, Rathore SS, Wang Y, The association of 6-minute walk performance and outcomes in stable outpatients with heart failure. J Card Fail 2004; 10:9–14.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Cote C, Cabral H, The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J 2004; 23:28–33.
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85 Suppl B:25–31.
   PubMed Web of Science ®Google Scholar
• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379:1341–1351.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SF. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc 2005; 2:8–11.
   PubMedGoogle Scholar
• Annual smoking-attributable mortality, years of potential life lost, and productivity losses—United States, 1997–2001. MMWR Morb Mortal Wkly Rep 2005; 54:625–628.
   PubMedGoogle Scholar
• Smoking-attributable mortality, years of potential life lost, and productivity losses–United States, 2000–2004. MMWR Morb Mortal Wkly Rep 2008; 57:1226–1228.
   PubMedGoogle Scholar
• Anthonisen NR, Connett JE, Enright PL, Hospitalizations and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166:333–339.
   PubMed Web of Science ®Google Scholar
• Stein PK, Nelson P, Rottman JN, Howard D, Ward SM, Kleiger RE, Heart rate variability reflects severity of COPD in PiZ α1-antitrypsin deficiency. Chest 1998; 113:327–333.
   PubMed Web of Science ®Google Scholar
• Stewart AG, Waterhouse JC, Howard P. Cardiovascular autonomic nerve function in patients with hypoxaemic chronic obstructive pulmonary disease. Eur Respir J 1991; 4:1207–1214.
   PubMed Web of Science ®Google Scholar
• Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, Crapo JD, Silverman EK, and the COPDGene Investigators. Clinical and radiographic predictors of GOLD–Unclassified smokers in the COPDGene study. Amer J Respir Criti Care Med 2011; 184:57–63.
   PubMed Web of Science ®Google Scholar